Implementation of a clinical decision support alert for the management of Clostridium difficile infection

Antibiotics

Volumn 4, Issue 4, 2015, Pages 667-674

  Revolinski, Sara ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Clinical decision support; Clostridium difficile; Order set

Indexed keywords

CREATININE; METRONIDAZOLE; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DECISION SUPPORT SYSTEM; FEMALE; HEALTH CARE PLANNING; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY;

EID: 85007147464     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics4040667     Document Type: Article

References (13)

1. Lassa, F.C.; Mu, Y.; Bamberg, W.M.; Beldavs, Z.G.; Dumyati, G.K.; Dunn, J.R.; Farley, M.M.; Holzbauer, S.M.; Meek, J.I.; Phipps, E.C.; et al. Burden of Clostridium difficile infection in the United States. N Engl. J. Med. 2015, 372, 825-834.
2. Campbell, R.; Dean, B.; Nathanson, B.; Haidar, T.; Strauss, M.; Thomas, S. Length of stay and hospital costs among high-risk patients with hospital-origin Clostridium difficile-associated diarrhea. J. Med. Econ. 2013, 16, 440-448.
3. Reveles, K.R.; Lee, G.C.; Boyd, N.K.; Frei, C.R. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. Am. J. Infect. Control. 2014, 42, 1028-1032.
4. Zimlichman, E.; Henderson, D.; Tamir, O.; Franz, C.; Song, P.; Yamin, C.K.; Keohane, C.; Denham, C.R.; Bates, D.W. Health-care associated infections. JAMA Intern. Med. 2013, 173, 2039-2046.
5. Maroo, S.; LaMont, J.T. Recurrent Clostridium difficile. Gastroenterology 2006, 130, 1311-1316.
6. Cohen, S.H.; Gerding, D.N.; Johnson, S.; Kelly, C.P.; Loo, V.G.; McDonald, L.C.; Pepin J.; Wilcox, M.H. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America. Infect. Control. Hosp. Epidemol. 2010, 31, 431-455.
7. Surawicz, C.M.; Brandt, L.J.; Binion, D.G.; Ananthakrishnan, A.N.; Curry, S.R.; Gilligan, P.H.; McFarland, L.V.; Mellow, M.; Zuckerbraun, B.S. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am. J. Gastroenterol. 2013, 108, 478-498, doi:10.1038/ajg.2013.4.
8. Dellit, T.H.; Owens, R.C.; McGowan, J.E., Jr.; Gerding, D.N.; Weinstein, R.A.; Burke, J.P.; Huskins, C.; Paterson, D.L.; Fishman, N.O.; Carpenter, C.F.; et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 2007, 44, 159-177.
9. Braxton, C.C.; Gerstenberger, P.A.; Cox, G.G. Improving antibiotic stewardship: Order sest implementation to improve prophylactic antimicrobial prescribing in the outpatient surgical setting. J. Ambul. Care Manage. 2010, 33, 131-140.
10. Hall, A.B.; Montero, J.; Cobian, J.; Regan, T. The effects of an electronic order set on vancomycin dosing in the ED. Am. J. Emerg. Med. 2015, 33, 92-94.
11. Pestotnik, S.L. Expert clinical decision support systems to enhance antimicrobial stewardship programs: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2005, 25, 1116-1125.
12. Zar, F.A.; Bakkanagari, S.R.; Moorthi, K.M.L.S.T.; Davis, M.B. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin. Infect. Dis. 2007, 45, 302-307.
13. Johnson, S.; Louie, T.J.; Gerding, D.N.; Cornely, O.A.; Chasan-Taber, S.; Fitts, D.; Gelone, S.P.; Broom, C.; Davidson, D.M. for the Polymer Alternative for CDI Treatment (PACT) Investigators. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: Results from two multinational, randomized, controlled trials. Clin. Infect. Dis. 2014, 59, 345-354.